Money Info Show

Investment News Show

Money Info Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

 

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King, Charles Moskowitz and Gary Cella together with radio broadcasting professional Greg Wyatt.

Watch Money Info

Investment News Show Replays

 

October 23, 2018 Show:

Hemp Health Products Stock

The October 23, 2018 Money Info Show featured Hemp and Health Products Company

CEO Bruce Hannan and Demand Brands Inc.

Hemp Health Products Stock

Demand Brands Inc. was acquired by Innovativ Media Group, Inc. August 9, 2018

 

See News On Acquisition Here

http://innovativmedia.com/wp-content/uploads/2018/08/INMG-Press-Release-August-9-2018.pdf

 

See Demand Brands Corporate Site: http://www.DemandBrandsInc.com

 

See the Demand Brands Investors Information Page Here

 

Here a replay of the Bruce Hannan Interview:

 

Here a replay of the Complete Show:

 

UPDATE: The Company name and Symbol has changed since the show. The Company is now called

Demand Brands Inc.

And is traded under the symbol DMAN

 

Get DMAN stock quote here

Undervalued Hemp Products Stocks

Hemp and Health Products Stock Information

Demand is a collection of leading businesses and brands operating in the Health, Wellness, Cannabis Edibles, Hemp and CBD sectors which is managed by industry veterans Bruce Hannan and Guy Peckham.

Demand Brands, Inc. is associated with an array businesses and brands consumers have come to know and trust that market innovative and leading Edibles, Oils, Vapes and Beverage products and manages ventures in the Hemp + Healthy, Cannabis/CBD Superfoods and Education and Technology sectors that promote healthy lifestyles for women, men, children and pets.

undervalued Cannabis products stock

marijuana health products stocks

“We believe the acquisition of Demand Brands will substantially enhance the Company’s P&L and create significant near and long term shareholder value. Bruce and Guy have long and successful track records with both public and private businesses and in developing innovative brands and exceptional products”.

— Tom Coleman, CEO of Innovativ Media

 

“Vending into Innovativ Media Group will give Demand access to new capital markets and currency to target acquisitions which will facilitate developing our assets and scaling operations more rapidly”.

— Bruce Hannan, CEO of Demand Brands

 

“Our industry is growing and consolidating at a fast clip and this transaction will give us an opportunity to target some excellent operating businesses and add to our portfolio of companies. I am looking forward to working with Bruce and building on our prior experience at Premium Brands Holdings (PBH-T)”

— Demand Brands President Guy Peckham

 

DEMAND BRANDS is actively targeting strategic acquisitions, partnerships and joint ventures to expand its portfolio of unique brands and companies and acquire additional market share in this $3.7 Trillion dollar industry.

Members of the DEMAND BRANDS team were an integral part of the expansion of Premium Brands Holding Corp, a Canadian Company, with current revenues exceeding 1 Billion Dollars. Our experienced Managers, with successful track records in manufacturing, production, branding, sales and distribution and a strong belief in the positive benefits of its products, share a passion and commitment to building a dynamic company in main and niche market categories with a solid foundation for growth.

 

Innovativ Media Group (Innovativ) is a developer, producer and distributor of digital entertainment and other multi-media content. It is a principle partner in CannaNet.TV, which operates LocalCannabisDispensary.Com and Kush Processing. http://innovativmedia.com

Hemp and Health Products Stock Demand Brands NEWS

Demand Brand acquires DMR and all of its MigraPure™ breakthrough Migraine therapy assets — SEE NEWS RELEASE

 

The patented MigraPure™ products are a result of 15 years of research and development including 4 successful clinical studies. A MigraPure™ Hemp version will also be introduced in the near term. Migraines are an illness that plagues approximately 20% of all women, 10% of men and 10% of children and adolescents. The market is substantial and is expected to grow to $8.7 Billion by 2020.

 

Hemp and Health Products Stock DMAN, Demand Brands,

On Social Media

Facebook  https://www.facebook.com/demandbrands

Twitter  http://www.twitter.com/demandbrands

Instagram https://www.instagram.com/demandbrands/

 

————————— Older Shows ——————–

August 7, 2018 Show:

Artificial Intelligence In Cancer Research

The August 7th show features  

Precision Therapeutics

(NASDAQ Trading Symbol: AIPT)

formerly Skyline Medical.

Precision Therapeutics is at the Forefront in Medical Advancement and Innovation.

The Company Arose as a Joint Venture Between Skyline Medical and Helomics. Precision Therapeutics Is Now Bringing Precision Medicine to the Diagnosis and Treatment of Cancer.

Listen to the interview:

AIPT AI for cancer research

Harnessing the power of artificial intelligence, Precision Therapeutics is working with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for cancer patients, which is leading to much more effective treatments for the patients of today and tomorrow.

Artificial Intelligence Cancer Research

See the Precision Therapeutics Website: PrecisionTherapeutics.com

See the Investors Information Page

Get AIPT Stock Quote and Stock Information

Precision Therapeutics Is at the Forefront in Medical Advancement and Innovation. The Company Arose as a Joint Venture Between Skyline Medical and Helomics. Skyline Medical’s Automated ‘streamway’ System Transformed How Laboratories Safely Dispose of Medical Fluid Waste. By Joining Forces with Helomics, Precision Therapeutics Is Now Bringing Precision Medicine to the Diagnosis of Cancer. Harnessing the Power of Artificial Intelligence, Precision Therapeutics Is Working with the Pharmaceutical, Diagnostic and Biotech Industries to Develop Highly Customizable Assessment Methods for Cancer Patients, Leading to Much More Effective Treatments.

AIPT AI Cancer Research

Precision Therapeutics (NASDAQ: AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, through its Skyline Medical division.

Skyline Medical Inc. has a fully automated, patented, and FDA cleared surgical fluid disposal device-the STREAMWAY System-that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment.

 

Crystal Research Issues AIPT Executive Informational Overview

Crystal Research Paper on Precision Therapeutics Inc.

http://investors.skylinemedical.com/static-files/d662c363-d0f8-4bdb-b11b-02355d08d7e1

 

 

 

 

 

October 10, 2017 Show Replay

Lab Research Equipment Stock

Pressure Biosciences, Inc. (PBIO)

on Investing News Show

The October 24, 2017 Show features a Live Interview with Richard Schumacher, President, Chief Executive Officer and Director of

Laboratory Instrument Stock Pressure Biosciences, Inc.

Featuring pressure cycling technology laboratory instrumentation equipment company.

Pressure Biosciences, Inc.

(Stock Symbol: PBIO)

Watch a replay of the interview:

Replay will be posted tomorrow

 

See corporate site: PressureBiosciences.com

Get PBIO Stock Quote

Lab Instruments Stock

See Executive Summary

See Latest Company Press Releases

 

Watch a replay of the full show:

 

Mr. Schumacher discusses the addition of 5 news sales representatives, European expansion and new joint venture distributors.

Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions — SEE News Report

 

Pressure BioSciences’ Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and Ireland — SEE News Report

 

CEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn — See News Report

 

Pressure BioSciences, Inc. Issued First Two Patents on Widely-Applicable, High Pressure-Based Ultra Shear Technology (“UST”) — See News Report

Lab Instruments Medical Products Stock

Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market.

Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure.

PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 275 PCT systems in approximately 160 sites worldwide.

There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.

PBIO primary application development and sales efforts are in the biomarker discovery and forensics areas.

Customers also use PBIO products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.

Lab Instruments Company

See Pressure BioSciences Life Sciences Lab Instruments Products Page

To date, PBIO has installed over 250 PCT systems in approximately 160 sites worldwide. 

Richard T. Schumacher

President, Chief Executive Officer and Director

Mr. Richard T. Schumacher, the founder of our Company, has served as a director of Pressure BioSciences since the formation of its legacy business, Boston Biomedica, Inc., in 1978. He has served as CEO of Pressure BioSciences since April 2004 and President since September, 2004.

He previously served as CEO and Chairman of the Board of Boston Biomedica from 1992 to February, 2003 and as President from 1986 to August 1999. Mr. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Mr. Schumacher received a BS in Zoology from the University of New Hampshire.

 

October 10, 2017 Show Replay

iSIGN Media Corp.

Software-as-a-service Company

on Investment News Show

The October 10th show features an interview with

Alex Romanov
President & Chief Executive Officer, Director of

iSIGN Media Corp.

Software-as-a-service Company

Stock Symbol:

ISD TSX

ISDSF (US Markets)

 

Hear a replay of the interview:

 

Watch a replay of Full show:

See corporate site: iSignMedia.com

Get iSign Media Stock Quote

See Corporate Information Page 

See Latest Company NEWS

 

iSIGN Media Corp.

Interactive Marketing Solutions Stock

 

iSIGN Media, based in Toronto, is a data-focused, software-as-a-service (SaaS) company that is a pioneer in gathering point-of-sale data and mobile shopper preferences to generate actionable data and reveal valuable consumer insights.

Creators of the Smart Antenna, an interactive proximity marketing technology, iSIGN enables brands to deliver targeted messaging, personalized offers and loyalty perks to consumer mobile devices on location and in real-time. iSIGN’s data gathering capabilities provide analytics on price points, typical purchases, in-store dwell time and other shopper metrics that identify emerging consumer behaviors.

These insights enable smarter business decisions and provide ROI metrics for more transparent marketing. iSIGN delivers relevant, timely messages on an opt-in basis at no charge to consumers, transmitting rich media to consumer mobile devices via trusted, mature Bluetooth® and WiFi technologies without the restrictions associated with iBeacon. Proven to increase brand engagement and customer loyalty, iSIGN generates preference-based, predictive “clean data” without compromising consumer privacy.

Interactive Marketing Solutions Stock News

iSIGN Media Corp.’s patent pending Interactive Marketing Solution (IMS 3.1) provides businesses with an effective and easy to use content delivery vehicle combined with real time data capturing to provide the perfect business intelligence tool. Our complete IMS offering including our patent pending software and smart antenna makes location based interactive proximity advertising to mobile devices measurable, accountable, flexible and affordable.

Interactive Marketing Solutions Stock News

Software-as-a-service (SaaS) Company Stock News

iSIGN Media Announces its Push Sensor Technology is Demonstrable to Existing and New Customers

iSIGN Media Solutions Inc., a leading provider of interactive mobile advertising solutions that serves brands, commercial locations, retailers and service providers throughout North America, today announced the completion of a pre-production engineering demo unit housing its patent pending Push Sensor technology.

The Push Sensor builds upon the Company’s existing patented technology to provide a non-app and non-download system for integrating messaging and coupon solutions with Google Chrome and Apple Passbook, with additional integration for Google Wallet and Apple Pay expected, when messaging/coupons drives purchasing.  This system allows for seamless interaction with all mobile devices, especially Smartphones, including iPhones.

 

iSIGN Media Announces the Completion of its Security Alert Messaging Solution

 

iSIGN Media Provides an Update on Installations and Activities

 

Interactive Marketing Solutions Stock

Alex Romanov President & Chief Executive Officer, Director

Alex Romanov, CEO, has enjoyed a diverse work life rich in experience. He worked with industry leaders in his formative years, such as Motorola where he learned how to build and run a business. He then ported that expertise to Alpine Electronics, where for 16 years, with his leadership team, he built that organization into an industry leader.

At Alpine Electronics, which was a direct subsidiary of Alps Electric Japan, he established the Canadian operation and in three short years grew the brand to enjoy #1 market share deposing then industry leaders Pioneer and Kenwood. Hand in hand with Alpine’s growth as a premium brand, Mr. Romanov, established and grew its OEM business, establishing Alpine standard equipment in BMW, Honda, Lamborghini and other automotive icons.

After leaving Alpine in 1996 Mr. Romanov established his own marketing agency, bringing leading consumer electronic brands such as AST Computers into his portfolio and establishing sales and distribution for them, again winning the top market share for them over then industry giants Compac, IBM and Packard Bell.

Mr. Romanov lead the acquisition team when Alpine acquired Luxman home audio, and parlayed this experience complimented by his rich experience later in his career as he developed and co-founded Spherex Inc., which developed and marketed an Xbox gaming audio system. Spherex was sold to a US concern in 2005. Alex has been iSIGN’s Chief Executive Officer since November 2007 and has successfully restructured the company, positioning it for rapid growth worldwide.

Software-as-a-service (SaaS) company Stock News

 

September 19, 2017 Show

Lab Research Equipment Stock

Pressure Biosciences, Inc. (PBIO)

on Investing News Show

Live Interview with Richard Schumacher, 

President, Chief Executive Officer and Director of

Laboratory Instrument Stock Pressure Biosciences, Inc.

Featuring pressure cycling technology laboratory instrumentation equipment company.

Pressure Biosciences, Inc.

(Stock Symbol: PBIO)

Watch a replay of the interview:

See corporate site: PressureBiosciences.com

Get PBIO Stock Quote

Lab Instruments Stock

See Executive Summary

See Latest Company Press Releases

Watch a replay of the whole show:

 

 

Mr. Schumacher discusses the latest PBIO news:

Pressure BioSciences’ Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year

SEE News Report

Lab Instruments Medical Products Stock

Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market.

Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure.

PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 275 PCT systems in approximately 160 sites worldwide.

There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.

PBIO primary application development and sales efforts are in the biomarker discovery and forensics areas.

Customers also use PBIO products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.

Lab Instruments Company

See Pressure BioSciences Life Sciences Lab Instruments Products Page

To date, PBIO has installed over 250 PCT systems in approximately 160 sites worldwide. 

Richard T. Schumacher

President, Chief Executive Officer and Director

Mr. Richard T. Schumacher, the founder of our Company, has served as a director of Pressure BioSciences since the formation of its legacy business, Boston Biomedica, Inc., in 1978. He has served as CEO of Pressure BioSciences since April 2004 and President since September, 2004.

He previously served as CEO and Chairman of the Board of Boston Biomedica from 1992 to February, 2003 and as President from 1986 to August 1999. Mr. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Mr. Schumacher received a BS in Zoology from the University of New Hampshire.

 

 

September 12, 2017 Show

Electric Boat Technology Stock on Investing News Show

Leo  Motors, Inc.

Stock Symbol: LEOM

Featured on Investing News Show

 

Visit Corporate Site: LeoMotors.com

Get LEOM Stock Quote

See Latest Leo Motors News

 

Interview with Robert Kang Chairman & CEO

Listen to a replay of the interview:

Leo Motors, Inc. is a electric boat and vehicle technology stock involved in Electric Power Boat Technology, Electric Motor Development, Energy Storage Devices, Electric Conversion Kits and Electric Boat Technology.

 

Listen to a replay of the Full Show:

Electric Vehicle Technology Stock

Mr Kang discusses new developments for Leo Motors proprietary new electric powerboat propulsion system.   The Company has developed an electric power system for both small and medium sized fishing and power boats as the main propulsion system. The electric boats are used throughout Korea, China and Japan for
the important coastal farming of numerous commercial products such as abalone and seaweed.

electric powered boat

Electric Power Boat Technology NEWS

LGM Delivered the First Inland Water Fishing Boat – See News — LGM, a subsidiary of Leo Motors Inc. (OTCQB: LEOM) delivered the first high-speed electric fishing boat to the Korean government. Appointed as the sole partner of Korea’s electric boat program, LGM has developed the high-speed electric boat with the aid of a government subsidy. The boat passed all required testing for certification from the Korean government.

This electric boat operates at speeds faster than its internal combustion engine (ICE) counterparts. The sailing range of LGM’s e-boat is longer than ICE fishing boat as LGM uses its patented cartridge battery system which enables the sailor to freely extend the range of the e-boat.

 

LGM’s Clean Boat to Sail in the Chinese National Park — See News — LGM Enters MOU with Shanghai Bosster IMP & EXP for Sales of Electric Propellant Systems

 

LGM Debuts 660 HP Electric Power Boat Propulsion SystemSee News — LGM, Inc., a subsidiary of Leo Motors Inc. (OTCQB: LEOM) unveiled their proprietary new electric powerboat propulsion system at the 2017 Busan Boat Show in Korea. The new LGM powerboat electric propulsion system produces up to 660 horse power (HP) and is compatible with most power boats and yachts.

 

Leo has patents for the electric battery industry. They have developed a lithium battery that can operate vehicles in sub-zero climates.

Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats.

Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.

 

In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN (Controller Area Network) based, which enables mobile diagnostics between mobile devices and boats using the Leo technology.

 

 

Robert Kang

Chairman & CEO

Dr. Kang has a Ph. D. in marketing and worked in the field of international advertising and corporate marketing for more than 30 years.  He began his carrier at Oricom, the largest ad agency in Korea and a McCann Ericson affiliate. He founded Ad Express and On&Off and managed the firms for 11 years. He served as president of Pico North Asian, a multinational global event marketing company in Hong Kong.  Dr. Kang has worked in the Company as CEO and interim CFO during 2008~2011. Currently, he is working as the chairman of Talent Donation  Consultant Association and Head Professor of Business Consultant Starter School of the City Government of Seoul. Dr. Kang focuses on  business development and financing of Leo Motors. He received his BS (literature) from Korea University, MA (Advertising) from University of Oregon, and Ph. D. (Marketing) at Dongguk University.

 

 

 

September 5, 2017 Show:

Infusion Systems Medical Products Stock

Undervalued Medical Products Stocks

 

Undervalued Medical Products Stock With Infusion Systems Featured on Money Info Investment News

 

The September 5, 2017 where to invest now Money Info Investing News Show features a live interview with

 

Andy Sealfon, CEO of RMS Medical Systems, Inc.

(Stock Symbol: REPR)

Visit the corporate website: RMSMedicalProducts.com

Click Here For REPR stock quotes,

trading charts and latest news releases

See RMS Medical Investors Information Page with financials

 

Mr. Sealfon announces RMS Freedom Infusion System Cleared By FDA for Both Subcutaneous and Intravenous Indications — See News Release

 

Hear a replay of the interview:

 

Part 1 of the show features where to invest now market strategies discussion with Greg Wyatt, Mike King and Charles Moskowitz.

Hear a replay of Part 1 of the show:

 

Undervalued Medical Stocks

 

RMS Medical Products

Inspiration for health, freedom for living

 

RMS Receives FDA Clearance for 510(k)

See News Release

RMS Freedom Infusion System Cleared for Both Subcutaneous and Intravenous Indications

September 05, 2017  — Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announces the FDA issued a new 510(k) clearance for the RMS “Integrated Catch-Up Freedom Syringe Driver Infusion System” effective August 31, 2017.  The Freedom System is the first and only fully integrated mechanical system cleared by the FDA for a wide range of medications and flow rates.

Manufactured in the U.S.A., the System is cleared for subcutaneous and intravenous indications, including specific subcutaneous immunoglobulins and antibiotics.  The Freedom System reduces the need for stocking other specialty infusion devices for these different applications.

 

Where To Invest Undervalued Stocks

RMS Medical Products MISSION:

To improve the Quality of Life of patients around the world

through the design, development and delivery of the

highest quality innovative therapeutic solutions.

 

The most valuable home infusion system

We work to help reduce healthcare costs

through the increasing success of home infusion

with our Freedom DynEQ™ infusion systems.

 

Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC®Hand Held Medical Suction.

We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.

best small cap medical stocks to buy

Small cap medical stocks to buy

The Freedom60 has a proprietary technology

that makes it desirable for the

delivery of medications in a wide variety of  therapies.

Medical Products Stock news

It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

best small cap stocks to buy

 

 

Money Info Show

Replay Archives

Hear Replays Of

September, August, July and June Shows HERE 

 

Hear Replays of
March, April, May 2017 Shows HERE

Investing News Show Where To Invest Information

 

Hear Replays of February 2017 to December 2016 Shows:

Where To Invest In Small Cap Stocks

 

Hear Replays of

December 2016 to July 2016 Shows

HERE

 

Hear Replays of

June 2016 to April 2016 Shows

HERE

 

Hear Replays of

March 2016 to January 2016 Shows

HERE

 

Hear Replays of 

December 2015 to October 2015 Shows

Click Here

Hear Replays of 

December 2015 to October 2015 Shows

Click Here

 

Hear Replays of 

September 2015 to June 2015 Shows

Click Here

 

Hear Replays of 

June 2015 to April 2015 Shows

Click Here   

investment news show

The Princeton Research Money Info Show features

where to invest now,

stock market, business, economy and

financial investment news.

 

Stock Options Trading Alerts Update:

In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.

See http://www.princetonresearch.com/options-trading.htm to get in today.

Money Info Investment News Show

3 Trackbacks / Pingbacks

  1. | Small Cap Oil Stocks To Buy
  2. Small Cap Gaming Stocks Investment News – Buying and Selling Penny Stock
  3. | Undervalued Small Cap Tech Stocks

Leave a Reply